Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
AAPS PharmSciTech ; 25(6): 148, 2024 Jun 27.
Artículo en Inglés | MEDLINE | ID: mdl-38937387

RESUMEN

Our study aimed to explore the potential of using nanostructured lipid carriers (NLCs) to enhance the topical administration of ß-sitosterol, a bioactive that is poorly soluble in water. Here, we have taken advantage of the unique characteristics that cubosomes have to provide as a drug delivery system. These characteristics include a large surface area, thermal stability, and the capacity to encapsulate molecules that are hydrophobic, amphiphilic, and hydrophilic. The cubosomal formulation was optimized by building a central composite design. The optimum dispersion exhibited a particle size of 88.3 nm, a zeta potential of -43, a polydispersity index of 0.358, and drug entrapment of 95.6%. It was composed of 15% w/w oleic acid and 5% w/w pluronic F127. The optimized cubosome dispersion was incorporated into a sponge formulation. The optimized cubosome sponge achieved a higher drug release compared with the cubosome dispersion. The SEM micrograph of the selected sponge showed that it has an interwoven irregular fibrous lamellar structure with low density and high porosity. The in-vivo data revealed that topical application of the ß-sitosterol cubosomal sponge showed significant higher wound closure percentage relative to the ß-sitosterol product (Mebo)®.


Asunto(s)
Quemaduras , Quitosano , Portadores de Fármacos , Tamaño de la Partícula , Sitoesteroles , Sitoesteroles/química , Sitoesteroles/administración & dosificación , Animales , Quitosano/química , Portadores de Fármacos/química , Quemaduras/tratamiento farmacológico , Liberación de Fármacos , Cicatrización de Heridas/efectos de los fármacos , Masculino , Sistemas de Liberación de Medicamentos/métodos , Ratas , Poloxámero/química , Interacciones Hidrofóbicas e Hidrofílicas , Nanoestructuras/química , Administración Tópica
2.
Acta Parasitol ; 67(2): 773-783, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35067863

RESUMEN

PURPOSE: Although praziquantel (PZQ) has a wide use as an anti-schistosome agent, many of its imperfections and side effects have been reported in many studies. The current study aims to evaluate the curative effect of a natural dandelion extract (Taraxacum officinale) on schistosomiasis either alone or in combination with PZQ based on parasitological, immunological, histopathological and molecular investigations. METHODS: Mice were experimentally infected with Schistosoma mansoni cercariae and then divided into four groups, Schistosoma spp.-infected untreated group (IC group), Schistosoma spp.-infected group of mice treated with dandelion (I-Dn group), Schistosoma spp.-infected group of mice treated with PZQ (I-PZQ group), and Schistosoma spp.-infected group of mice treated with both PZQ and dandelion (I-PZQ + Dn group). Treatment started 45 days' post-infection. Besides, non-infected, non-treated mice served as the negative healthy control group (HC group). RESULTS: The present results indicated that dandelion administration significantly reduced the worm burden, ova number, and the number and diameter of hepatic granulomas as compared to the untreated infected group. The results also showed that the levels of IL-6 and TNF-α were significantly decreased in the combined treatment group (I-PZQ + Dn) as compared to the I-PZQ group. Administration of dandelion-only remarkably reduced AST and ALT activities associated with schistosomiasis. Moreover, hepatic DNA damage assessed by comet assay was significantly inhibited in the combined treated group compared to the infected untreated and PZQ treated groups. CONCLUSION: The results concluded that combined treatment of PZQ and dandelion extract improved immune response, decreased the number and diameter of granulomas, and inhibited DNA damage, indicating a reduction in liver fibrosis associated with schistosomiasis. The present study focused on the potential effect of dandelion as an adjunct medication for therapeutic properties of PZQ.


Asunto(s)
Antihelmínticos , Hepatopatías , Esquistosomiasis mansoni , Esquistosomiasis , Taraxacum , Animales , Antihelmínticos/farmacología , Antihelmínticos/uso terapéutico , Granuloma/tratamiento farmacológico , Hígado/patología , Hepatopatías/tratamiento farmacológico , Ratones , Extractos Vegetales/farmacología , Praziquantel/farmacología , Praziquantel/uso terapéutico , Schistosoma mansoni , Esquistosomiasis/tratamiento farmacológico , Esquistosomiasis/patología , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomiasis mansoni/patología
3.
Environ Toxicol ; 36(10): 2105-2115, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34236127

RESUMEN

This work was designed to explore the protective role of resveratrol (RES) against sulfoxaflor (Sulfx)-induced reproductive toxicity in adult male rats. The animals were divided into six groups: Control group, Sulfx treated groups (79.5 and 205 mg/kg/day), RES treated group (20 mg/kg/day), RES + Sulfx treated groups (20 mg/kg Res + 79.5 or 205 mg/kg Sulfx) orally for 28 consecutive days. Testicular samples were collected from all groups at the end of the treatment period. Tissue supernatants were isolated for oxidative stress and cellular energy parameters; tissue samples were prepared for histopathological examination. In addition, caspase-3 activity was calculated to assess spermatogenesis. Finally, DNA laddering assay was performed to detect DNA fragmentation as a hallmark of apoptosis. Our results showed that Sulfx treatment induced a significant increase in testicular levels of MDA, NOx, GSSG and reduced GSH level and cellular energy parameters in a dose-dependent manner compared to the control group. The results were confirmed by histopathological study which showed pathological changes in Sulfx treated groups. A significant increase in caspase 3 and DNA fragmentation was also observed. However, concomitant administration of RES to Sulfx -treated rats showed significant modulation against Sulfx-induced reproductive toxicity and attenuated the biochemical, apoptotic and histopathological changes. In conclusion, our results suggest that exposure to Sulfx at the two selected doses induces testicular toxicity and these effects can be ameliorated by supplementation of RES.


Asunto(s)
Antioxidantes , Testículo , Animales , Antioxidantes/metabolismo , Apoptosis , Masculino , Estrés Oxidativo , Piridinas , Ratas , Resveratrol , Compuestos de Azufre , Testículo/metabolismo
4.
Andrologia ; 52(1): e13394, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31762066

RESUMEN

Paclitaxel (taxol) is one of the most powerful anticancer drugs but it possesses toxic effects on male reproductive system. Propolis, from folkloric remedy, have antioxidant, anti-inflammatory and anticancer effects. The present study established to examine the protective impact of Propolis against malformation of semen induced by taxol. Twenty-four male rats equally divided into four groups. Group I (normal control); group II, administrated Propolis alone; group III, taxol-treated group received taxol; group IV, co-administered of taxol and Propolis extract. After 4 weeks of treatment, the semen were collected and testis 24 hr after the last treatment. Sperm count, motility, viability and sperm morphology were assayed. Tissue supernatants were isolated for oxidative stress, cell energy parameters and 8-OHdG. DNA damage was evaluated using Comet assay in testes. Our results confirmed that taxol-induced significant reduction in sperm count, motility, viability and recorded marked elevation in sperm abnormalities. Also, taxol caused increased in 8-OHdG and DNA damage versus that recorded in control group. Treatment with Propolis improving semen quality and protected testis from detrimental effects of taxol and minimises its toxicity. In conclusions, Oral administration of Propolis modulates the toxic impact of taxol by amelioration semen quality, diminishing oxidation state, DNA damage and preserving cell energy.


Asunto(s)
Antineoplásicos Fitogénicos/efectos adversos , Apiterapia/métodos , Oligospermia/terapia , Paclitaxel/efectos adversos , Própolis/administración & dosificación , Administración Oral , Animales , Daño del ADN/efectos de los fármacos , Modelos Animales de Enfermedad , Humanos , Masculino , Neoplasias/tratamiento farmacológico , Oligospermia/inducido químicamente , Estrés Oxidativo/efectos de los fármacos , Ratas , Semen/efectos de los fármacos , Motilidad Espermática/efectos de los fármacos , Testículo/efectos de los fármacos , Testículo/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA